Mara Persano

1.1k total citations
31 papers, 274 citations indexed

About

Mara Persano is a scholar working on Oncology, Molecular Biology and Hepatology. According to data from OpenAlex, Mara Persano has authored 31 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 9 papers in Molecular Biology and 9 papers in Hepatology. Recurrent topics in Mara Persano's work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Colorectal Cancer Treatments and Studies (9 papers) and Pancreatic and Hepatic Oncology Research (9 papers). Mara Persano is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Colorectal Cancer Treatments and Studies (9 papers) and Pancreatic and Hepatic Oncology Research (9 papers). Mara Persano collaborates with scholars based in Italy, United States and Belgium. Mara Persano's co-authors include Mario Scartozzi, Eleonora Lai, Marco Puzzoni, Pina Ziranu, Clelia Donisi, Andrea Pretta, Stefano Mariani, Nicole Liscia, Giorgio Astara and Valeria Pusceddu and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Hepatology and British Journal of Cancer.

In The Last Decade

Mara Persano

22 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mara Persano Italy 6 159 126 84 57 46 31 274
Colan Ho-Yen United Kingdom 7 138 0.9× 122 1.0× 80 1.0× 43 0.8× 24 0.5× 12 288
Nicole Liscia Italy 7 226 1.4× 131 1.0× 104 1.2× 112 2.0× 73 1.6× 29 374
Shuya Bai China 10 137 0.9× 178 1.4× 108 1.3× 34 0.6× 44 1.0× 22 312
Hajrah Khawaja United Kingdom 7 115 0.7× 147 1.2× 54 0.6× 57 1.0× 26 0.6× 8 272
Sabina Delcuratolo Italy 9 153 1.0× 127 1.0× 129 1.5× 69 1.2× 49 1.1× 14 333
Shenglan Huang China 11 69 0.4× 150 1.2× 95 1.1× 66 1.2× 48 1.0× 23 295
Fangfang Bu China 8 107 0.7× 173 1.4× 90 1.1× 32 0.6× 26 0.6× 9 285
Laura Ogle United Kingdom 8 165 1.0× 115 0.9× 107 1.3× 41 0.7× 39 0.8× 10 332
Shi‐Xun Lu China 12 120 0.8× 109 0.9× 64 0.8× 96 1.7× 24 0.5× 21 277
Qiuyun Luo China 9 116 0.7× 188 1.5× 49 0.6× 39 0.7× 56 1.2× 24 310

Countries citing papers authored by Mara Persano

Since Specialization
Citations

This map shows the geographic impact of Mara Persano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mara Persano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mara Persano more than expected).

Fields of papers citing papers by Mara Persano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mara Persano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mara Persano. The network helps show where Mara Persano may publish in the future.

Co-authorship network of co-authors of Mara Persano

This figure shows the co-authorship network connecting the top 25 collaborators of Mara Persano. A scholar is included among the top collaborators of Mara Persano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mara Persano. Mara Persano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Camera, Silvia, Federico Rossari, Silvia Foti, et al.. (2025). HER2 Pathway in Biliary Tract Cancer: A Snapshot of the Current Understanding and Future Directions. Targeted Oncology. 20(2). 269–280.
3.
Foti, Silvia, Silvia Camera, Federico Rossari, et al.. (2024). Developing targeted therapeutics for hepatocellular carcinoma: a critical assessment of promising phase II agents. Expert Opinion on Investigational Drugs. 33(8). 839–849.
4.
Germani, Marco Maria, Rossana Intini, Maria Bensi, et al.. (2024). Treatment of patients with BRAF-mutated metastatic colorectal cancer after progression to encorafenib and cetuximab: data from a real-world nationwide dataset. ESMO Open. 9(4). 102996–102996. 4 indexed citations
5.
6.
7.
Ziranu, Pina, Andrea Pretta, Raffaele Murru, et al.. (2023). New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression. Cancers. 15(4). 1212–1212. 9 indexed citations
8.
Rimini, Margherita, Andrea Casadei‐Gardini, Mara Persano, et al.. (2023). Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: A large, real-life, worldwide population.. Journal of Clinical Oncology. 41(4_suppl). 579–579. 4 indexed citations
9.
10.
Pretta, Andrea, Pina Ziranu, Riccardo Giampieri, et al.. (2022). Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment. Digestive and Liver Disease. 55(5). 655–660. 2 indexed citations
11.
Pretta, Andrea, Eleonora Lai, Mara Persano, et al.. (2022). Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment. World Journal of Hepatology. 14(7). 1319–1332. 11 indexed citations
12.
Rimini, Margherita, Valentina Burgio, Lorenzo Antonuzzo, et al.. (2022). Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis. Targeted Oncology. 17(5). 591–596. 5 indexed citations
13.
Pretta, Andrea, Clelia Donisi, Mara Persano, et al.. (2022). Mismatch repair proteins (MMR) expression as predictive factor in locally advanced rectal cancer.. Journal of Clinical Oncology. 40(4_suppl). 182–182. 1 indexed citations
14.
Persano, Mara, Andrea Casadei‐Gardini, Valentina Burgio, et al.. (2022). Five years of lenvatinib in hepatocellular carcinoma: are there any predictive and/or prognostic factors?. Expert Review of Anticancer Therapy. 23(1). 19–27. 3 indexed citations
15.
Pretta, Andrea, Clelia Donisi, Mara Persano, et al.. (2021). P-128 Influence of anti-diabetic medications on the outcomes of patients with pancreatic ductal adenocarcinoma and type 2 diabetes mellitus. Annals of Oncology. 32. S142–S142. 1 indexed citations
16.
Giampieri, Riccardo, Pina Ziranu, Alessandro Bittoni, et al.. (2021). Retrospective Comparative Analysis of KRAS G12C vs. Other KRAS Mutations in mCRC Patients Treated With First-Line Chemotherapy Doublet + Bevacizumab. Frontiers in Oncology. 11. 736104–736104. 6 indexed citations
17.
Puzzoni, Marco, Riccardo Giampieri, Simone Mariani, et al.. (2021). 417P Liquid biopsy driven anti-EGFR rechallenge in metastatic colorectal cancer. Annals of Oncology. 32. S543–S544. 1 indexed citations
18.
Donisi, Clelia, Marco Puzzoni, Pina Ziranu, et al.. (2021). Immune Checkpoint Inhibitors in the Treatment of HCC. Frontiers in Oncology. 10. 601240–601240. 92 indexed citations
19.
Donisi, Clelia, Francesco Atzori, Mariele Dessì, Mara Persano, & Mario Scartozzi. (2019). Safe chemotherapy for treating early breast cancer in G6PD-deficient patients. Annals of Oncology. 30. iii33–iii33.
20.
Lai, Eleonora, Marco Puzzoni, Pina Ziranu, et al.. (2019). New therapeutic targets in pancreatic cancer. Cancer Treatment Reviews. 81. 101926–101926. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Colan Ho-Yen Breakdown of academic impact, for papers by Nicole Liscia Breakdown of academic impact, for papers by Shuya Bai Breakdown of academic impact, for papers by Hajrah Khawaja Breakdown of academic impact, for papers by Sabina Delcuratolo Breakdown of academic impact, for papers by Shenglan Huang Breakdown of academic impact, for papers by Fangfang Bu Breakdown of academic impact, for papers by Laura Ogle Breakdown of academic impact, for papers by Shi‐Xun Lu Breakdown of academic impact, for papers by Qiuyun Luo
Rankless by CCL
2026